Physician profile
Crystal Tank
NPI 1043639453
$2,450.20
in general payments reported to CMS, 2019-2025
15 companies · $823 in 2025
The $823 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.53 · 2021: $124 · 2022: $525 · 2023: $723 · 2024: $230 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $506.92 | 2022-2025 | Farxiga, Breztri |
| Edwards Lifesciences Corporation | $316.45 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $291.06 | 2022-2025 | |
| Teleflex LLC | $282.56 | 2023-2024 | Urolift |
| Abbott Laboratories | $242.79 | 2023-2025 | Coroflow, Pressurewire |
| Novo Nordisk INC | $196.04 | 2025 | Wegovy |
| Medtronic, INC. | $187.03 | 2025 | Symplicity G3, Interstim |
| Abbvie INC. | $101.20 | 2022 | |
| Exact Sciences Corporation | $86.43 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $79.37 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Corcept Therapeutics | $57.27 | 2025 | Korlym |
| Lilly USA, LLC | $53.57 | 2024-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $19.62 | 2025 | |
| Dynavax Technologies Corporation | $18.03 | 2025 | Heplisav-B |
| Amgen INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Tank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.